This article is more than 5 years old. Information may no longer be current.

VIDEO: Quantiferon testing in a lupus clinical trial

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

SAN DIEGO — At the American College of Rheumatology Annual Meeting, Niti Goel, MD, discussed a post hoc analysis evaluating the utility of the QuantiFERON-Tuberculosis GOLD test (QFT) and repeat testing for indeterminate results in the screening of patients in a systematic lupus erythematosus clinical trial. According to Goel, repeat indeterminate QFT results for tuberculosis were infrequent.